Russia Prepares $10 COVID-19 Vaccine For International Launch
Aims To Compete With Pfizer On Efficacy, Undercut On Price
Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism.
You may also be interested in...
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
Our updated graphic tracker of key developments from the leading vaccine candidates.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.